Navigation Links
Viral infections: Identifying the tell-tale patterns

Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have identified the structural features that enable the innate immune system to discriminate between viral and endogenous RNAs in living cells.

When viruses infect cells, they take control of cellular metabolism and hijack cellular resources for the production of viral proteins. This process is dependent on viral RNA molecules that are delivered directly to (in the case of RNA viruses) and/or newly synthesized in the host cell, and provide the blueprints for the fabrication of viral proteins by the cell's translational apparatus. However, cells possess defense systems that are activated by specialized sensors that can distinguish viral RNAs from host RNAs. These proteins, three of which belong to the family of RIG-I like receptors (or RLRs), recognize and bind specifically to foreign RNAs. This in turn alerts the innate immune system, which proceeds to destroy the foreign RNAs, thus preventing the production of new virus particles. "Based on in-vitro experiments, it is known that RLR proteins bind to certain characteristic patterns in viral RNAs, but it had not been possible to isolate the precise RNA sequences bound by these proteins in living, virus-infected cells," says Professor Karl-Peter Hopfner of LMU's Genzentrum.

Tethering RNA to proteins with UV light

Hopfner, in collaboration with his colleagues Karl-Klaus Conzelmann (LMU), Johannes Sding (LMU) and Adolfo Garca-Sastre (Mount Sinai Hospital, New York), made use of a clever experimental strategy to get around this problem, which enabled them to purify and characterize ribonucleoprotein complexes containing viral RNAs from virus-infected cells. The intrinsic stability of the interaction between RLRs and viral RNAs is very low. So the researchers first had to stabilize the complexes in order to isolate them intact. For this purpose, they infected cells with measles virus, and incubated them in the presence of a chemically modified, photoactivatable RNA precursor, which is incorporated into newly synthesized viral RNAs. "Provided that the physical distance between an RNA and its binding protein is short enough, subsequent exposure of such cells to UV light induces the formation of a stable covalent bond between them," Hopfner explains.

The resulting RNA-protein complexes could then be isolated from the cells and, after detachment of the proteins, the nucleotide sequences of the RNAs could be determined. "This allowed us to determine how RLRs recognize foreign RNAs and how the latter differ from endogenous cellular RNAs," says Hopfner.

The researchers found that the RLR proteins RIG-I and MDA5 indeed recognize defined elements within viral RNAs in living cells that have been infected by measles virus. Like many other viruses, including the one that causes rabies, the measles virus possesses a single-stranded RNA genome. Unlike DNA viruses, it therefore delivers an RNA template directly into the host cell. However, this molecule must then be transcribed by its associated viral RNA polymerase to generate the mRNAs required for synthesis of viral proteins and propagation of the infection.

Sensors bind to specific regions

"And while RIG-I preferentially binds to certain sequence patterns found at the exposed ends of different viral RNAs both in vitro and in vivo, MDA5 rather surprisingly recognizes not the viral genome itself, but apparently certain regions located within viral mRNAs," Hopfner explains. Moreover, these regions differ in their base composition from sequences found in other viral RNAs, suggesting that MDA5 relies on these structural differences to discriminate between viral and endogenous RNAs.

Hopfner and his team now plan to investigate the interaction of RLRs with other viral nucleic acids, in order to obtain a clearer picture of the molecular mechanisms that enable these proteins to detect foreign RNAs. This should in turn shed light on why the innate immune system has difficulty in responding to particular viruses, and how RLR-associated autoimmune diseases such as rheumatoid arthritis arise. A better understanding of both of these issues could suggest new approaches to the treatment of both viral infections and autoimmunity.


Contact: Luise Dirscherl
Ludwig-Maximilians-Universitt Mnchen

Related biology news :

1. Nanocrystalline cellulose modified into an efficient viral inhibitor
2. Degradation of viral DNA in the cell nucleus is opening up new treatment
3. Zoonotic diseases and global viral pandemics
4. Science teaching goes viral
5. H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance
6. Antiviral enzyme contributes to several forms of cancer, University of Minnesota researchers say
7. Scientists identify promising antiviral compounds
8. Toward broad-spectrum antiviral drugs for common cold and other infections
9. Computer modeling technique goes viral at Brandeis
10. Electron-beam pasteurization of raw oysters may reduce viral food poisoning
11. Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies
Post Your Comments:
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
Breaking Biology Technology: